This report aims to provide a comprehensive presentation of the global market for Biosimilars, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilars.
The Biosimilars market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biosimilars market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosimilars manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
The global Biosimilars market size in 2022 is 35140.00 million US dollars, and it is expected to be 172308.95 million US dollars by 2029, with a compound annual growth rate of 25.50% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Biosimilars market include F. Hoffmann-La Roche Ltd. (US), Sandoz International GmbH (Switzerland), Dr. Reddy’s Laboratories Ltd. (India), Teva Pharmaceutical Industries Ltd. (Israel), and Pfizer Inc. (US). The share of the top 3 players in the Biosimilars market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Biosimilars market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Monoclonal Antibodies accounted for XX% of Biosimilars market in 2022. Recombinant Hormones share of XX%.
Blood Disorders accounted for XX% of the Biosimilars market in 2022. Growth Hormonal Deficiency accounts for XX%.
Chapter Outline
Chapter 1: Introduces the product overview, research purposes, and then includes economic analysis of global regions, inflation analysis, and the impact of the Russian-Ukrainian war on the market.
Chapter 2: Analysis of the competitive environment of Biosimilars market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and expansion in recent years.
Chapters 3-5: Segmented the global Biosimilars market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapter 6: Analyzes the main companies in the Biosimilars industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 7: Analyzes the Biosimilars business cost, including industrial chain and the proportion of business cost structure.
Chapter 8: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapters 9-10: Provide detailed Biosimilars market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 11: The main points and conclusions of the report.
Highlights-Regions
North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico
Player list
F. Hoffmann-La Roche Ltd. (US)
Sandoz International GmbH (Switzerland)
Dr. Reddy’s Laboratories Ltd. (India)
Teva Pharmaceutical Industries Ltd. (Israel)
Pfizer Inc. (US)
Samsung Bioepis (South Korea)
Biocon (India)
and Mylan N.V (US).
Types list
Monoclonal Antibodies
Recombinant Hormones
Immunomodulators
Anti-Inflammatory Agents
Other Product Classes
Application list
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Oncology
Other Applications
List of Tables and Figures
Figure Biosimilars Picture
Table Product Definition of Biosimilars
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Table Global Biosimilars Revenue ($) by Manufacturer (2018-2023)
Table Global Biosimilars Revenue Market Share by Manufacturer (2018-2023)
Figure Global Biosimilars Revenue Market Share by Manufacturer in 2023
Table Manufacturers Biosimilars Production Sites, Area Served, Product Types
Table Biosimilars Market Concentration Rate
Figure Global Top 5 and Top 10 Players Market Share by Revenue in 2023
Table Mergers & Acquisitions, Expansion Plans
Table Global Biosimilars Market Size by Type (2023 VS 2029)
Figure Global Biosimilars Market Share by Type 2018 VS 2022
Table Global Biosimilars Revenue and Market Size by Type (2018-2023)
Table Global Biosimilars Revenue and Market Share by Type (2018-2023)
Table Global Biosimilars Market Size by Application (2023 VS 2029)
Figure Global Biosimilars Market Share by Application 2018 VS 2022
Table Global Biosimilars Revenue Market Size by Application (2018-2023)
Table Global Biosimilars Revenue Market Share by Application (2018-2023)
Figure Global Biosimilars Revenue Market Size (2018-2023)
Table Biosimilars Market Size by Regions: 2018 VS 2023 VS 2029
Table Biosimilars Historic Revenue Market Size by Regions (2018-2023)
Table Biosimilars Historic Revenue Market Share by Regions (2018-2023)
Figure North America Biosimilars Revenue and Growth (2018-2023)
Table North America Biosimilars Revenue by Countries (2018-2023)
Table North America Biosimilars Revenue Market Share by Countries (2018-2023)
Table North America SWOT Analysis
Figure United States Biosimilars Revenue and Growth (2018-2023)
Figure Canada Biosimilars Revenue and Growth (2018-2023)
Table China SWOT Analysis
Figure China Biosimilars Revenue and Growth (2018-2023)
Figure Asia Pacific Biosimilars Revenue and Growth (2018-2023)
Table Asia-Pacific Biosimilars Revenue by Countries (2018-2023)
Table Asia-Pacific Biosimilars Revenue Market Share by Countries (2018-2023)
Table Asia Pacific SWOT Analysis
Figure Japan Biosimilars Revenue and Growth (2018-2023)
Figure Korea Biosimilars Revenue and Growth (2018-2023)
Figure Southeast Asia Biosimilars Revenue and Growth (2018-2023)
Figure India Biosimilars Revenue and Growth (2018-2023)
Figure Australia Biosimilars Revenue and Growth (2018-2023)
Figure EMEA Biosimilars Revenue and Growth (2018-2023)
Table EMEA Biosimilars Revenue by Countries (2018-2023)
Table EMEA Biosimilars Revenue Market Share by Countries (2018-2023)
Table EMEA SWOT Analysis
Figure Europe Biosimilars Revenue and Growth (2018-2023)
Figure Germany Biosimilars Revenue and Growth (2018-2029)
Figure France Biosimilars Revenue and Growth (2018-2029)
Figure UK Biosimilars Revenue and Growth (2018-2029)
Figure Italy Biosimilars Revenue and Growth (2018-2029)
Figure Russia Biosimilars Revenue and Growth (2018-2029)
Figure Nordic Biosimilars Revenue and Growth (2018-2029)
Figure Middle East Biosimilars Revenue and Growth (2018-2023)
Figure Africa Biosimilars Revenue and Growth (2018-2023)
Figure Latin America Biosimilars Revenue and Growth (2018-2023)
Table Latin America Biosimilars Revenue by Countries (2018-2023)
Table Latin America Biosimilars Revenue Market Share by Countries (2018-2023)
Table Latin America SWOT Analysis
Figure Brazil Biosimilars Revenue and Growth (2018-2023)
Figure Argentina Biosimilars Revenue and Growth (2018-2023)
Figure Mexico Biosimilars Revenue and Growth (2018-2023)
Table F. Hoffmann-La Roche Ltd. (US) Profile
Table Product Overview
Table F. Hoffmann-La Roche Ltd. (US) Biosimilars Revenue, Gross and Gross Margin (2018-2023)
Figure F. Hoffmann-La Roche Ltd. (US) Revenue and Growth Rate
Figure F. Hoffmann-La Roche Ltd. (US) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Sandoz International GmbH (Switzerland) Profile
Table Product Overview
Table Sandoz International GmbH (Switzerland) Biosimilars Revenue, Gross and Gross Margin (2018-2023)
Figure Sandoz International GmbH (Switzerland) Revenue and Growth Rate
Figure Sandoz International GmbH (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Dr. Reddy’s Laboratories Ltd. (India) Profile
Table Product Overview
Table Dr. Reddy’s Laboratories Ltd. (India) Biosimilars Revenue, Gross and Gross Margin (2018-2023)
Figure Dr. Reddy’s Laboratories Ltd. (India) Revenue and Growth Rate
Figure Dr. Reddy’s Laboratories Ltd. (India) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Teva Pharmaceutical Industries Ltd. (Israel) Profile
Table Product Overview
Table Teva Pharmaceutical Industries Ltd. (Israel) Biosimilars Revenue, Gross and Gross Margin (2018-2023)
Figure Teva Pharmaceutical Industries Ltd. (Israel) Revenue and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. (Israel) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Pfizer Inc. (US) Profile
Table Product Overview
Table Pfizer Inc. (US) Biosimilars Revenue, Gross and Gross Margin (2018-2023)
Figure Pfizer Inc. (US) Revenue and Growth Rate
Figure Pfizer Inc. (US) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Samsung Bioepis (South Korea) Profile
Table Product Overview
Table Samsung Bioepis (South Korea) Biosimilars Revenue, Gross and Gross Margin (2018-2023)
Figure Samsung Bioepis (South Korea) Revenue and Growth Rate
Figure Samsung Bioepis (South Korea) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Biocon (India) Profile
Table Product Overview
Table Biocon (India) Biosimilars Revenue, Gross and Gross Margin (2018-2023)
Figure Biocon (India) Revenue and Growth Rate
Figure Biocon (India) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table and Mylan N.V (US). Profile
Table Product Overview
Table and Mylan N.V (US). Biosimilars Revenue, Gross and Gross Margin (2018-2023)
Figure and Mylan N.V (US). Revenue and Growth Rate
Figure and Mylan N.V (US). Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Labor Cost Analysis
Figure Proportion of Manufacturing Cost Structure
Figure Biosimilars Industrial Chain Analysis
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Global Biosimilars Revenue Market Size Forecast by Type (2023-2029)
Table Global Biosimilars Revenue Market Share Forecast by Type (2023-2029)
Table Global Biosimilars Revenue Market Size by Application (2023-2029)
Table Global Biosimilars Revenue Market Share by Application (2023-2029)
Table Global Biosimilars Revenue Market Size by Region (2023-2029)
Table Global Biosimilars Revenue Market Share by Region (2023-2029)
Figure North America Biosimilars Forecast Revenue and Growth 2023-2029
Figure EMEA Biosimilars Forecast Revenue and Growth 2023-2029
Figure China Biosimilars Forecast Revenue and Growth 2023-2029
Figure Asia-Pacific Biosimilars Forecast Revenue and Growth 2023-2029
Figure Latin America Biosimilars Forecast Revenue and Growth 2023-2029
